| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |